How I treat Logo
howitreat.in

A user-friendly, frequently updated reference guide that aligns with international guidelines and protocols.

Osteopetrosis

Introduction:

  • It is a heterogenous group of disorders characterized by increased bone density due to defect in osteoclast differentiation and function.

 

Epidemiology:

  • Rare disorder
  • Autosomal recessive- 1 in 2,50,000 births
  • Autosomal dominant- 5 in 1,00,000 population

 

Pathogenesis:

  • Defect in osteoclast functioning due to various mutations
  • Increased bone density paradoxically weakens the bones, leading to fractures and osteomyelitis.

 

Classification (Genes affected in bracket):

  • Autosomal recessive osteopetrosis:
    • Classic (TCIRG)
    • Neuropathic (CLCN7, OSTM1)
      • Often have retinal atrophy
      • Osteopetrosis associated with renal tubular acidosis (Carbonic anhydrase II)
      • Associated with developmental delay, intracranial calcification
  • X Linked osteopetrosis, lymphedema, anhidroticectodermal dysplasia and immunodeficiency (IKBKG)
  • Intermediate osteopetrosis (CLCN7, PLEKHM I)
  • Autosomal dominant osteopetrosis/Albers- Schonberg disease (CLCN7)

 

Clinical Features (varying range of severity is noted from asymptomatic to very severe forms):

  • Bone marrow suppression- Symptoms due to pancytopenia
  • Skeletal deformities
    • Skull changes
      • Macrocephaly
      • Frontal bossing
      • Choanalatresia
      • Hydrocephalus
      • Narrowing of nerve foramina (Cranial nerve compression- II, VII and VIII)- Blindness, deafness, facial palsy
  • Dental abnormalities- Tooth eruption defects and dental caries
  • Short stature
  • Extramedullary hematopoiesis leading to hepatosplenomegaly
  • Hypocalcemia leading to tetanic seizures

 

Investigations:

  • Hemogram- Pancytopenia
  • X-Ray/ CT scan
    • Increased bone density, diffuse and focal sclerosis of varying severity
    • Modelling defects at metaphysis (Erlenmeyer Flask deformity)
    • Bone in bone appearance particularly in vertebrae and phalanges
    • Focal sclerosis of the skull base, pelvis and vertebral end plates- “Sandwich” vertebrae/ “rugger jersey” spine.
    • Pathological fractures
    • Osteomyelitis
  • S. Creatinine kinase B- Increased
  • S. Tartrate resistant acid phosphatase- Increased
  • BM biopsy
  • Genetic testing for gene defects

 

Prognosis:

  • Severe infantile forms: If untreated die within 1st decade of life due to bone marrow suppression.
  • Adult forms- Normal life expectancy

 

Differential Diagnosis:

  • Fluorosis
  • Beryllium, lead, bismuth poisoning
  • Myelofibrosis
  • Paget’s disease
  • Malignancies- Lymphoma, osteoblasticsecondaries

 

Treatment:

  • Supportive care:
    • Orthopedic management of fractures
    • Calcium and vitamin D for hypocalcemic seizures
    • Transfusion support for marrow failure
    • Surgical decompression of optic nerve
    • Dental surveillance and hygiene
  • Hematopoietic stem cell transplantation
    • Reserved for severe forms of disease, as it is associated with high morbidity and mortality
    • Better outcomes with transplants if done before 3 months of age
  • Interferon Gamma-1b can be used as bridge till HSCT is done

 

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Howitreat.in

Wish to Reach Hematologists?

Advertise with Us!

Know More

Home

About Us

Support Us

An Initiative of

Veenadhare Edutech Private Limited

1299, 2nd Floor, Shanta Nivas,

Beside Hotel Swan Inn, Off J.M.Road, Shivajinagar

Pune - 411005

Maharashtra – India

How I treat Logo
howitreat.in

CIN: U85190PN2022PTC210569

Email: admin@howitreat.in

Disclaimer: Information provided on this website is only for medical education purposes and not intended as medical advice. Although authors have made every effort to provide up-to-date information, the recommendations should not be considered standard of care. Responsibility for patient care resides with the doctors on the basis of their professional license, experience, and knowledge of the individual patient. For full prescribing information, including indications, contraindications, warnings, precautions, and adverse effects, please refer to the approved product label. Neither the authors nor publisher shall be liable or responsible for any loss or adverse effects allegedly arising from any information or suggestion on this website. This website is written for use of healthcare professionals only; hence person other than healthcare workers is advised to refrain from reading the content of this website.